- Home
- SFHG vs GDTC Comparison
SFHG vs GDTC Comparison
Compare SFHG & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFHG
- GDTC
- Stock Information
- Founded
- SFHG 1993
- GDTC 2018
- Country
- SFHG Hong Kong
- GDTC Singapore
- Employees
- SFHG N/A
- GDTC N/A
- Industry
- SFHG Publishing
- GDTC Biotechnology: Pharmaceutical Preparations
- Sector
- SFHG Consumer Discretionary
- GDTC Health Care
- Exchange
- SFHG Nasdaq
- GDTC Nasdaq
- Market Cap
- SFHG 18.9M
- GDTC 21.5M
- IPO Year
- SFHG 2024
- GDTC 2023
- Fundamental
- Price
- SFHG $0.78
- GDTC $2.27
- Analyst Decision
- SFHG
- GDTC Buy
- Analyst Count
- SFHG 0
- GDTC 1
- Target Price
- SFHG N/A
- GDTC $5.00
- AVG Volume (30 Days)
- SFHG 69.5K
- GDTC 13.1K
- Earning Date
- SFHG 04-16-2025
- GDTC 01-01-0001
- Dividend Yield
- SFHG N/A
- GDTC N/A
- EPS Growth
- SFHG N/A
- GDTC N/A
- EPS
- SFHG N/A
- GDTC N/A
- Revenue
- SFHG $19,760,935.00
- GDTC $368,838.00
- Revenue This Year
- SFHG N/A
- GDTC $5.37
- Revenue Next Year
- SFHG N/A
- GDTC N/A
- P/E Ratio
- SFHG N/A
- GDTC N/A
- Revenue Growth
- SFHG 30.89
- GDTC N/A
- 52 Week Low
- SFHG $0.55
- GDTC $1.20
- 52 Week High
- SFHG $24.00
- GDTC $4.05
- Technical
- Relative Strength Index (RSI)
- SFHG 53.75
- GDTC 70.54
- Support Level
- SFHG $0.71
- GDTC $1.82
- Resistance Level
- SFHG $0.80
- GDTC $2.07
- Average True Range (ATR)
- SFHG 0.05
- GDTC 0.10
- MACD
- SFHG 0.01
- GDTC 0.03
- Stochastic Oscillator
- SFHG 61.89
- GDTC 100.00
About SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.
About GDTC CytoMed Therapeutics Limited
CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.